Peter Harf is a German entrepreneur and businessperson who founded 5 companies, notably: Coty, Inc., Delete Blood Cancer and DKMS Foundation and who has been at the helm of 21 different companies. Presently, Dr. Harf is Chairman & Chief Executive Officer at Joh. A. Benckiser GmbH, Managing Director at Agnaten SE, Chairman of Bally UK Sales Ltd., Chairman & Managing Partner at JAB Holding Co. SARL, Executive Chairman of Coty, Inc. (which he founded in 1996), Chairman & Managing Partner at JAB Holding Co. LLC, Chairman at Coty Italia SRL, Chairman-Management Board at JAB Luxury GmbH, Chief Executive Officer at Donata Holding SE and Chief Executive Officer of Parentes SE (which are all subsidiaries of Agnaten SE), Managing Director at Lucresca SE and Chairman at Bally International AG. Dr. Harf is also Executive Chairman of Delete Blood Cancer (he founded the company) and Chairman at Deutsche Stiftung Leben Spenden (he founded the company in 1997) and on the board of 10 other companies.
Peter Harf previously occupied the position of Chairman of Anheuser-Busch InBev SA, Principal at The Boston Consulting Group, Inc., Chairman of Espresso House Holding AB, Chairman at Belstaff Group SA, Non-Executive Chairman at Jimmy Choo Group Ltd., Chairman at Espresso House Sweden AB, Chief Executive Officer for JAB Holdings II BV, Senior Vice President-Corporate Planning at AEG AG and Executive Chairman at DKMS gemeinnützige GmbH (he founded the company in 2004).
Dr. Harf received a doctorate from Universität zu Köln and an MBA from Harvard Business School.